| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 07/17/2001 | CA2126910C Isolation and structure of spongistatins 5, 7, 8, and 9 |
| 07/17/2001 | CA2104225C Method for the diagnosis and treatment of glutamic acid decarboxylase autoantigen associated diseases |
| 07/12/2001 | WO2001049829A1 Compositions and methods for efficient aav vector production |
| 07/12/2001 | WO2001049828A1 Mutated hepatitis b virus, its nucleic and protein constituents and uses thereof |
| 07/12/2001 | WO2001049827A1 Methods and compositions for reconstruction of multilayered tissue structures |
| 07/12/2001 | WO2001049825A1 Methods for protein transfer |
| 07/12/2001 | WO2001049824A2 Cell growth substrate hydrogels |
| 07/12/2001 | WO2001049717A2 Methods and compositions relating to modulation of hepatocyte growth, plasma cell differentiation or t cell subset activity by modulation of xbp-1 activity |
| 07/12/2001 | WO2001049317A2 Enhancing the immune response to an antigen by presensitizing with an inducing agent prior to immunizing with the inducing agent and the antigen |
| 07/12/2001 | WO2001049316A2 Use of a vector comprising a nucleic acid coding for an anti-angiogenic factor for treating corneal neovascularization |
| 07/12/2001 | WO2001049304A2 Aqueous ionic solutions and their uses in particular in ophthalmology |
| 07/12/2001 | WO2001049254A2 Method for producing a cosmetically applicable marine mud extract and product containing said marine mud extract |
| 07/12/2001 | WO2001049243A2 Veto cells effective in preventing graft rejection and devoid of graft versus host potential |
| 07/12/2001 | WO2001049133A1 Application of vicinal dithioglycol as food additive |
| 07/12/2001 | WO2001049113A1 Spore-like cells and uses thereof |
| 07/12/2001 | WO2001023528A8 Reversal of insulin-dependent diabetes by islet-producing stem cells, islet progenitor cells and islet-like structures |
| 07/12/2001 | WO2001007605A8 Immunosuppression by cell surface expression of recombinant cd154 |
| 07/12/2001 | WO2001002548A3 Methods for the propagation of lytic organisms |
| 07/12/2001 | WO2001000220A3 Lipoprotein lipase (lpl) variant therapeutics |
| 07/12/2001 | WO2000078928A3 Surface for cell culture |
| 07/12/2001 | WO2000078697A3 High molecular weight primary aliphatic alcohols obtained from beeswax and pharmaceutical use thereof |
| 07/12/2001 | WO2000074722A3 Modification of biological elements |
| 07/12/2001 | WO2000055318A8 Abc1 polypeptide and methods and reagents for modulating cholesterol levels |
| 07/12/2001 | WO2000032750A9 Transgenic circulating endothelial cells |
| 07/12/2001 | WO2000017321A9 Use of growth factors and hormones for expansion of mammalian cells and tissue engineering |
| 07/12/2001 | WO1999066031A3 Pharmaceutical factor vii preparation |
| 07/12/2001 | WO1999052541A3 Artery- and vein-specific proteins and uses therefor |
| 07/12/2001 | US20010007658 Medium and matrix for long-term proliferation of cells |
| 07/12/2001 | US20010007656 Introducing cells treated in vivo with DNA segment comprising transcription factor gene (c-Myc) and operably linked promoter sequence to patient |
| 07/12/2001 | DE19963628A1 Synergistic active agent combination of colostrum product, minerals and herbal component, useful as or in medicaments, foodstuffs, food supplements or cosmetics, e.g. for skin treatment |
| 07/12/2001 | DE19962456A1 Preparing tissue implant, useful for in vitro testing of pharmaceuticals, by expressing liquid from a homogeneous suspension of cells and matrix components |
| 07/12/2001 | DE19960490A1 Regenerationsmittel Regenerant |
| 07/12/2001 | DE10000157A1 Synergistic active agent combination of colostrum product, minerals and herbal component, useful as or in medicaments, foodstuffs, food supplements or cosmetics, e.g. for skin treatment |
| 07/12/2001 | CA2396399A1 Methods for protein transfer |
| 07/12/2001 | CA2396222A1 Veto cells effective in preventing graft rejection and devoid of graft versus host potential |
| 07/12/2001 | CA2395456A1 Hydrogels |
| 07/12/2001 | CA2395117A1 Spore-like cells and uses thereof |
| 07/12/2001 | CA2394597A1 Enhancing the immune response to an antigen by presensitizing with an inducing agent prior to immunizing with the inducing agent and the antigen |
| 07/11/2001 | EP1114166A1 Method for down-regulating osteoprotegerin ligand activity |
| 07/11/2001 | EP1113821A1 In situ injection of antigen-presenting cells with genetically enhanced cytokine expression |
| 07/11/2001 | EP1113807A2 Cell mediated gene delivery using muscle derived cells for treating muscle- and bone-related injury or dysfunction |
| 07/11/2001 | EP0969865A4 Mhc class ii antigen-presenting systems and methods for activating cd4?+ t cells |
| 07/11/2001 | CN1303442A Method |
| 07/11/2001 | CN1303429A Therapeutic applications of mature FLINT (mFLINT) polypeptides or OPG3, member of TNF receptor superfamily |
| 07/11/2001 | CN1303425A PNS cell lines and methods of use therefor |
| 07/11/2001 | CN1303279A Topical transdermal treatments |
| 07/11/2001 | CN1302664A Gene medicine for treating hemophilia B and its preparing process |
| 07/11/2001 | CN1302642A Chinese medicine for treating tuberculosis and hepatitis |
| 07/11/2001 | CN1302639A Tendon-conditioning analgetic |
| 07/11/2001 | CN1302636A 'Yishentongbi' pill for treating hyperosteogeny and its preparing process |
| 07/11/2001 | CN1302623A Chinese patent medicine for treating gastrosis and its preparing process |
| 07/11/2001 | CN1302616A Powdered medicine for treating simple baby diarrhea |
| 07/11/2001 | CN1302615A Process for clarifying raw liquid extract of tetrodotoxin |
| 07/11/2001 | CN1302614A Medicine for treating baby diarrhea |
| 07/11/2001 | CN1302613A Compound pancreatic ribonucleate for injection |
| 07/11/2001 | CN1068223C Pill for treating hepatopathy |
| 07/11/2001 | CN1068219C Slow-released analgesic suppository and its preparation process |
| 07/11/2001 | CN1068218C Plaster for curing prolapse of lumbar intervertebral disk |
| 07/11/2001 | CN1068216C 'Shilongqingxue' instant particle for treating hematencephalon |
| 07/11/2001 | CN1068214C Luxian oral liquid and its preparation method |
| 07/11/2001 | CN1068213C External-use medicine for treating hyperosteogeny, and lumbage and leg pain |
| 07/11/2001 | CN1068212C Chinese patent medicine for treating hyperlipemia |
| 07/11/2001 | CN1068211C 'Jiulong' pill for setting of fracture |
| 07/11/2001 | CN1068209C Chinese patent medicine for curing tuberculosis of lung and preparation process thereof |
| 07/11/2001 | CN1068207C Cap for preventing and curing cerebral hemorrhage |
| 07/10/2001 | US6258870 Gels for encapsulation of biological materials |
| 07/10/2001 | US6258791 Enhanced delivery of nucleic acid into humans or animals |
| 07/10/2001 | US6258778 Methods for accelerating bone and cartilage growth and repair |
| 07/10/2001 | US6258597 Stimulation of hematopoietic cells in vitro |
| 07/10/2001 | US6258577 Adding nontoxic amount of endogenous photosensitizer to fluid, exposing to photoradiation to activate sensitizer and allowing it to deactivate the microorganism; viral decontamination of blood and blood products |
| 07/10/2001 | US6258383 Immunostimulant absorbed through mouth |
| 07/10/2001 | US6258362 Genetically attenuated; vaccine contains polysaccharide and/or amino acid source, buffer, and monosaccharide, oligosaccharide, or sugar alcohol |
| 07/10/2001 | US6258357 Extracting allogeneic human donor blood aliquot; separating t-cells; oxidatingstressing to reduce cytokines; administering to patient undergoing bone marrow transplant |
| 07/10/2001 | US6258354 Method for homing hematopoietic stem cells to bone marrow stromal cells |
| 07/10/2001 | US6258353 Porcine neural cells and their use in treatment of neurological deficits due to neurodegenerative diseases |
| 07/10/2001 | CA1341269C Viral inactivation and purification of active proteins |
| 07/05/2001 | WO2001048187A2 A molecular switch for regulating mammalian gene expression |
| 07/05/2001 | WO2001048154A1 Maturation-promoting agent for immature dendritic cells |
| 07/05/2001 | WO2001048153A1 Reconstructing organs from decellularized biomaterial scaffold |
| 07/05/2001 | WO2001048152A1 Tissue engineering using mandibular cells |
| 07/05/2001 | WO2001048151A1 Cells capable of differentiating into heart muscle cells |
| 07/05/2001 | WO2001048150A1 Cells capable of differentiating into heart muscle cells |
| 07/05/2001 | WO2001048149A1 Adult bone marrow-origin cell capable of differentiating into heart muscle cell |
| 07/05/2001 | WO2001048148A1 Process for ex vivo formation of mammalian bone and uses thereof |
| 07/05/2001 | WO2001047963A2 Inhibitors of complement activation, their preparation and use |
| 07/05/2001 | WO2001047962A2 Attenuated microorganisms for the treatment of infection |
| 07/05/2001 | WO2001047953A2 Antibodies against plasma cells |
| 07/05/2001 | WO2001047561A1 Hyaluronic acid in the treatment of cancer |
| 07/05/2001 | WO2001047543A2 Activation and inhibition of the immune system |
| 07/05/2001 | WO2001047539A1 Pharmaceutical composition for preventing and treating erectile impotence using purified sumsoo extract |
| 07/05/2001 | WO2001047536A1 Propolis water extract and method for the preparation thereof, and water-soluble propolis powder |
| 07/05/2001 | WO2001047535A2 Pharmaceutical composition comprising snake venom and method for its manufacture |
| 07/05/2001 | WO2001047373A1 Honey based food product for relief of stomach and intestine complaints and compressed product comprising said composition |
| 07/05/2001 | WO2001002019A3 Control of gene expression |
| 07/05/2001 | WO2001002005A3 Treatment of dentritic cells for induction of immune tolerance |
| 07/05/2001 | WO2000073478A3 Recombinant adenoviral vectors expressing chimeric fiber proteins for cell specific infection and genome integration |
| 07/05/2001 | WO2000061622A3 Genes associated with diseases of the kidney |
| 07/05/2001 | WO2000055621A8 Blood leucocyte apheresis for treatment of disease |
| 07/05/2001 | WO2000046355A8 Telomerase reverse transcriptase transcriptional regulatory sequences |
| 07/05/2001 | WO2000034483A9 Compounds and methods for treatment and diagnosis of chlamydial infection |